Inovio Pharmaceuticals, Inc. (INO) — 分析师展望 / 分析师共识目标价为. 基于 17 位分析师评级, 共识为 看涨 — 9 买入, 6 持有, 2 卖出.
分析师共识目标价为 $6.00, 上涨空间为 440.5% 相对于当前价格 $1.11.
分析师预估 每股收益(EPS)为 $-4.21 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-3.95 vs 预期 $-4.21 (超预期 +6.1%). 2025: 实际 $-1.81 vs 预期 $-2.27 (超预期 +20.3%). 分析师准确度: 84%.
INO 股票 — 12个月价格预测
$6.00
▲ +440.54% 上涨空间
平均目标价
Based on 17 Wall Street analysts offering 12-month price targets for Inovio Pharmaceuticals, Inc., the price target is $6.00.
平均目标价相对最新价格 $1.11 变动 +440.54%。
INO 分析师评级
Buy
基于过去3个月内 17 位分析师对 Inovio Pharmaceuticals, Inc. 的评级
EPS 预测 — INO
84%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$3.95
vs Est –$4.21
▲ 6.5% off
2025
Actual –$1.81
vs Est –$2.27
▲ 25.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — INO
65%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▲ 38.7% off
2025
Actual $0.000B
vs Est $0.000B
▼ 31.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
